Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
Netflix
NFLX
|
+$753M |
| 3 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$749M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$662M |
| 5 |
Walmart Inc
WMT
|
+$405M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$426M |
| 3 |
Meta Platforms (Facebook)
META
|
+$372M |
| 4 |
TSMC
TSM
|
+$331M |
| 5 |
Pinduoduo
PDD
|
+$319M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.23% |
| 2 | Technology | 1.7% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Communication Services | 0.67% |
| 5 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11401
MacroGenics
MGNX
$257M
| $110K | ﹤0.01% |
68,541
-155,252
| -69% | -$244K |
|
11402
Evolution Petroleum
EPM
$130M
| $110K | ﹤0.01% |
+31,079
| New | +$131K |
|
|
CD
11403
Chaince Digital Holdings
CD
$374M
| $110K | ﹤0.01% |
22,134
-27,266
| -55% | -$316K |
|
11404
BuzzFeed
BZFD
$100M
| $110K | ﹤0.01% |
118,239
-235,854
| -67% | -$298K |
|
11405
Hennessy Advisors
HNNA
$79.6M
| $109K | ﹤0.01% |
11,406
-15,147
| -57% | -$150K |
|
11406
CALL
Neumora Therapeutics
NMRA
$271M
| $109K | ﹤0.01% |
61,100
+24,600
| +67% | +$53.9K |
|
11407
CALL
Douglas Elliman
DOUG
$166M
| $109K | ﹤0.01% |
46,100
-4,400
| -9% | -$11.3K |
|
11408
ProShares UltraShort MidCap400
MZZ
$4.29M
| $109K | ﹤0.01% |
13,765
+2,558
| +23% | +$21K |
|
11409
CALL
CEMIG Preferred Shares
CIG
$5.64B
| $109K | ﹤0.01% |
54,500
+23,300
| +75% | +$47.7K |
|
|
KLRS
11410
Kalaris Therapeutics
KLRS
$95.2M
| $109K | ﹤0.01% |
+12,856
| New | +$82.2K |
|
|
SNBR
11411
CALL
DELISTED
Sleep Number
SNBR
| $108K | ﹤0.01% |
12,800
-67,900
| -84% | -$429K |
|
11412
Cognition Therapeutics
CGTX
$97.9M
| $108K | ﹤0.01% |
+79,993
| New | +$130K |
|
|
ARBK
11413
Argo Blockchain
ARBK
$42.3M
| $108K | ﹤0.01% |
31,564
+31,040
| +5,924% | +$1.99M |
|
|
IRHOU
11414
Iron Horse Acquisitions II Corp Units
IRHOU
| $107K | ﹤0.01% |
+10,791
| New | +$107K |
|
|
LITS
11415
Lite Strategy Inc
LITS
$33.4M
| $107K | ﹤0.01% |
81,202
-44,220
| -35% | -$83.5K |
|
11416
Gray Television
GTN
$497M
| $107K | ﹤0.01% |
22,071
-172,617
| -89% | -$845K |
|
|
CVAC
11417
DELISTED
CureVac
CVAC
| $107K | ﹤0.01% |
23,604
-6,655
| -22% | -$34.1K |
|
11418
PUT
Cato Corp
CATO
$52.7M
| $107K | ﹤0.01% |
34,500
-14,900
| -30% | -$54.8K |
|
11419
CALL
National CineMedia
NCMI
$246M
| $107K | ﹤0.01% |
27,400
+15,200
| +125% | +$63K |
|
|
SVA
11420
DELISTED
Sinovac Biotech, Ltd
SVA
| $106K | ﹤0.01% |
16,430
| – | – |
|
11421
Security National Financial
SNFCA
$232M
| $106K | ﹤0.01% |
+12,352
| New | +$99.6K |
|
11422
PUT
Ardmore Shipping
ASC
$705M
| $106K | ﹤0.01% |
+10,000
| New | +$119K |
|
11423
CALL
Akebia Therapeutics
AKBA
$242M
| $105K | ﹤0.01% |
65,300
-55,300
| -46% | -$116K |
|
11424
Broadway Financial
BYFC
$112M
| $105K | ﹤0.01% |
14,155
+1,710
| +14% | +$11.1K |
|
11425
PUT
Hyliion Holdings
HYLN
$632M
| $105K | ﹤0.01% |
56,900
-29,200
| -34% | -$58.8K |
|
Similar funds
Jeff Yass's Q4 2025 Portfolio in Review
As of Q4 2025, Jeff Yass held 14,094 positions worth $868B, down 0.79% from $875B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2025 filing shows 1,864 new, 4,890 increased, 5,380 reduced and 1,914 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2025 buy was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2025, an estimated $1.17B increase.
- Jeff Yass's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.08B.
- Jeff Yass fully exited Innovator US Equity Power Buffer ETF September in Q4 2025, selling an estimated $26.5M.
- Jeff Yass's ten largest holdings make up 24% of its $868B portfolio in Q4 2025.
- Jeff Yass opened 1,864 new positions and closed 1,914 in Q4 2025.
- Jeff Yass's portfolio value fell 0.79% quarter-over-quarter to $868B.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.